Modules 3 and 4 of the EASL/EFSUMB Ultrasound of the Liver course are now available on EASL Campus. Module 3 – Focal liver lesions; the liver and biliary system Course description: The third module of the EASL/EFSUMB Basics of Ultrasound course takes a detailed look at focal liver lesions. You wi…
The HCC: Management of the side effects of immune checkpoint inhibitors course* is now available on EASL Campus. Course description : In this fascinating discussion, four of the leading experts in the field of hepatocellular carcinoma (HCC) discuss the use of immune checkpoint inhibitors in the t…
The Lancet-EASL Commission is tackling liver diseases in Europe and overcoming unmet needs, stigma and inequities. The Commission is quantifying the burden of liver disease in Europe and addressing optimal diagnosis and standards of care for patients with liver diseases – closing the gaps between…
A pioneering European research project, designed to develop new diagnostic tests to assess patients with Non-Alcoholic Fatty Liver Disease (NAFLD) has expanded giving access to more patients. Incorporating several new partners also enables access to even more state-of-the art technologies. Liver …
EASL, the European Association for the Study of the Liver, is now calling for nominations for a new Scientific Committee member to join the Governing Board for a 3 year term starting in April 2020. European National Associations are invited to submit nominations but EASL members living in Europe …
Call for schools 2021 EASL would like to provide its members with the ability to participate by opening a call for programme outline proposals and proposed topics. In 2021, EASL plans to present two clinical and one basic school, to be held at the end of June/beginning of July. In early 2016 the …
Professor Paolo Angeli has been elected Editor-in-Chief of the Journal of Hepatology – the flagship journal of the European Association for the Study of the Liver (EASL) Prof. Paolo Angeli was selected by the EASL Governing Board, with his appointment validated in April 2019 during EASL’s general…
Health care professionals and patient groups are working together to find out more about the experience of patients with autoimmune liver conditions across Europe. The results of this survey will be used by EASL (The European Association for the Study of the Liver) and by RARE Liver ERN – the Eur…
Dear Colleague EASL has been commissioned by the UK journal, The Lancet to work together to create an EASL Lancet Commission on Liver Disease in Europe. I am chairing the Paediatric and Rare disease Group and we wish to identify the model of care for paediatric liver disease across Europe in orde…
Starting September 2019 Hainsworth will serve as the interface between the EASL Governing Board and the organisation`s Geneva and Brussels operations, ensuring high quality and effective implementation of the Governing Board`s policies and decisions. Hainsworth has worked for 25 years in the inte…
